Using a TP53-specific grading system based on the recurrence of TP53 variants in multiple independent genomic repositories (cancer shared datasets (CSD)), we have previously defined a set of 480 variants as certified oncogenic variants (see Material and Methods) [20]. Here, TP53 is linked to cancer.